| [1] |
LI Yifan, QIN Chuanyu, ZENG Xi, LU Yajiao, LIAO Guangdong, KANG Leni, YANG Ying, ZHOU Min, XI Mingrong, YANG Chunxia, LI Jing.
Analysis of the acceptance and influencing factors of self-collection urine HPV testing in cervical cancer screening
[J]. Journal of Practical Oncology, 2025, 39(5): 412-417.
|
| [2] |
LI Xudong, LIU Tong.
The single cell transcriptome sequencing reveals the role and prognostic value of PCLAF and ERO1A in the progression of breast cancer
[J]. Journal of Practical Oncology, 2025, 39(5): 418-427.
|
| [3] |
LUO Qiyuan, SHAO Hongchao, ZHOU Shaohua, YE Mushi.
The current research status and prospect of the pathogenesis,influencing factors and surgical prevention and treatment strategies of inguinal hernia after prostate cancer surgery
[J]. Journal of Practical Oncology, 2025, 39(5): 445-449.
|
| [4] |
LYU Rui, ZHEN Linlin.
Research progress on bone microenvironment-mediated drug resistance in breast cancer bone metastasis
[J]. Journal of Practical Oncology, 2025, 39(5): 450-456.
|
| [5] |
SU Shaofei, ZHANG Enjie, LIU Jianhui, GAO Yan.
Exploring the causal relationship between 20 metabolites and ovarian cancer risk based on Mendelian randomization
[J]. Journal of Practical Oncology, 2025, 39(3): 191-200.
|
| [6] |
LIU Pan, KONG Bin, ZANG Jiahui, WANG Xinyue, SUN Yue, WANG Lu, XU Wanhai.
The effect of anti-angiogenic nanopeptides on delaying the progression in clear cell renal carcinoma by inhibiting the dual signaling pathways of VEGF and TIE-2
[J]. Journal of Practical Oncology, 2025, 39(2): 116-125.
|
| [7] |
WANG Rui, MA Deyuan, JIA Wangqiang, GUAN Quanlin.
Application and progress of nano-medicine mediated cuproptosis in the breast cancer treatment
[J]. Journal of Practical Oncology, 2025, 39(2): 144-150.
|
| [8] |
WANG Shuai, LI Qiqing, LI Rui, XU Tiefeng.
Advances in the application of nanoparticles in the diagnosis and treatment of breast cancer
[J]. Journal of Practical Oncology, 2025, 39(2): 151-156.
|
| [9] |
WANG Mengfei, XU Boqun.
Advances in immunotherapy for locally advanced cervical cancer
[J]. Journal of Practical Oncology, 2025, 39(2): 157-161.
|
| [10] |
WANG Ru, ZHANG Hongxia.
Research progress on the application of magnetic resonance imaging technology in predicting lymphatic vascular invasion in breast cancer
[J]. Journal of Practical Oncology, 2025, 39(2): 162-168.
|
| [11] |
KOU Shuai, WANG Yuping, SUN Xiaoxia, REN Juanjuan.
Analysis of incidence and mortality of ovarian cancer in China from 1992 to 2021 based on age-period-cohort model
[J]. Journal of Practical Oncology, 2025, 39(1): 7-12.
|
| [12] |
ZHANG Hua, Nurbia Ibibulla, LU Pengfei, JIA Chunli, PEI Xuanxuan, BAO Yongxing.
Effect and mechanism of CXCL8 on the paclitaxel sensitivity of cervical cancer cells
[J]. Journal of Practical Oncology, 2025, 39(1): 13-20.
|
| [13] |
LI Xiaoli, CAO Sujuan, HU Xiaomao, DENG Yujie, TANG Liting, ZHANG Zhongshan.
Effects of miRNA-383-5p targeting CIP2A on the proliferation,invasion,migration and apoptosis of bladder cancer cells
[J]. Journal of Practical Oncology, 2025, 39(1): 30-38.
|
| [14] |
GU Wen, ZHOU Lan, JIA Yanni, HUANG Weidong.
Validation of measurement attributes for QLU-C10D scale in breast cancer patients
[J]. Journal of Practical Oncology, 2025, 39(1): 49-55.
|
| [15] |
SHI Changyong, ZHOU Zizhen, ZHOU Guanglin, XIONG Yimin.
The values of DCE-MRI quantitative parameters combined with NCAPH in the diagnosis of early breast cancer
[J]. Journal of Practical Oncology, 2025, 39(1): 56-60.
|